Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

Effects of Ketorolac on Post-Operative Febrile Morbidity and Pain Management in Abdominal Myomectomy Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00845754

Enrollment

112

Registered

2009-02-18

Start date

1999-09-30

Completion date

2001-08-31

Last updated

2009-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile Morbidity, Pain

Keywords

Post-operative febrile morbidity, Post-operative pain management

Brief summary

The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Interventions

DRUGketorolac

15mg IV every6 hours for 4doses

DRUGsaline

15mg IV every 6hrs for 4 doses

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Ant patient undregoing abdominal myomectomy

Exclusion criteria

* Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS

Design outcomes

Primary

Measure	Time frame
Post-operative febrile morbidity	Inital 24hrs post-operative

Secondary

Measure	Time frame
Post-operative pain management	Initial 24hrs post-operative

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026